- Home
- BHFAO vs SNN Comparison
BHFAO vs SNN Comparison
Compare BHFAO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHFAO | SNN |
|---|---|---|
| Founded | N/A | 1856 |
| Country | United States | United Kingdom |
| Employees | 1400 | 16988 |
| Industry | Life Insurance | Industrial Specialties |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 14.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BHFAO | SNN |
|---|---|---|
| Price | $16.67 | $34.16 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.25 |
| AVG Volume (30 Days) | 51.4K | ★ 736.5K |
| Earning Date | N/A | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.19% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.58 |
| Revenue Next Year | N/A | $5.60 |
| P/E Ratio | ★ N/A | $64.97 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.19 | $26.02 |
| 52 Week High | $21.94 | $38.79 |
Technical Indicators
Market Signals| Indicator | BHFAO | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 52.79 | 57.17 |
| Support Level | $16.65 | $32.03 |
| Resistance Level | $17.48 | $37.23 |
| Average True Range (ATR) | 0.31 | 0.57 |
| MACD | 0.06 | 0.28 |
| Stochastic Oscillator | 65.44 | 83.48 |
Price Performance
Historical ComparisonAbout BHFAO Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.